12:02 PM EST - Antibe Therapeutics Inc. : Will file today an amended and restated preliminary short form prospectus with securities regulators in Ontario, British Columbia and Alberta, to amend and restate the preliminary short form prospectus dated May 24, relating to the Company’s marketed public offering of units for minimum gross proceeds of $3,000,000 and maximum gross proceeds of $5,000,000. Antibe Therapeutics Inc.
shares V.ATE are trading down $0.005 at $0.11.
